Report cover image

Shanghai Green Valley Pharmaceutical Co., Ltd. - Strategic SWOT Spotlight

Publisher Quaintel Research
Published Sep 04, 2024
Length 51 Pages
SKU # QTELR19136185

Description

Shanghai Green Valley Pharmaceutical Co., Ltd. - Strategic SWOT Spotlight


Shanghai Green Valley Pharmaceutical Co., Ltd. - Strategic SWOT Spotlight is a comprehensive and easily accessible overview of The Shanghai Green Valley Pharmaceutical Co., Ltd.'s business operations. It provides a Snapshot of the company's position in the industry compared to competitors. The report includs key executives, products and services, ESG spotlight, Corporate Strategy, Business Description, Helicopter view of SWOT Analysis, Competitive Landscape and latest events.

Key Highlights

Shanghai Green Valley Pharmaceutical Co., Ltd. is a pharmaceutical company that specializes in developing and manufacturing high-quality medications for various health conditions. They offer a wide range of products and services, including prescription drugs, over-the-counter medications, and medical devices. Their product line includes treatments for chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders. They also offer medications for acute conditions like pain relief, allergies, and infections. In addition to their pharmaceutical products, Shanghai Green Valley Pharmaceutical Co., Ltd. also provides services such as clinical trials, drug research and development, and patient education programs. They are committed to providing safe and effective medications to improve the health and well-being of individuals worldwide. Founded in 2018, the company is headquartered in Pudong New Area, Shanghai, China.

Shanghai Green Valley Pharmaceutical Co., Ltd. in the News:-
  • 13-May-2022 - Announcement on Early Termination of GV-971 Global Multi-Center Phase III Clinical Trial
  • 23-Dec-2021 - GV-971 Gets Included in China National Reimbursement Drug ListGV-971 Gets Included in China National Reimbursement Drug List
  • 02-Aug-2021 - GV-971 Global Phase III Clinical Trial Completes First Patient Dosed in Greater China
  • 25-Oct-2018 - Novel Drug Treatment Shows Improved Cognition in a Phase 3 Clinical Trial in Persons with Mild-to-Moderate Alzheimer's Disease in China
  • 25-Oct-2018 - GV-971: Spearheading Global Drug Development for Alzheimer's Disease with A New Perspective
Scope

Company Fundamentals:- These fundamentals offer valuable insights into Shanghai Green Valley Pharmaceutical Co., Ltd.'s operations, geographical presence, products and services, ESG spotlight, Corporate Strategy, Business Description and SWOT spotlight, aiding in a comprehensive understanding of the organization.

Reasons to Buy
  • Helicopter view of company's internal and external factors through SWOT analysis - Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers. - Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations. - Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Table of Contents

51 Pages
Table of Contents
Tables
Charts
Shanghai Green Valley Pharmaceutical Co., Ltd. - Key Company Facts
Shanghai Green Valley Pharmaceutical Co., Ltd. - Company Description
Shanghai Green Valley Pharmaceutical Co., Ltd. - Top Executives
Shanghai Green Valley Pharmaceutical Co., Ltd. - Head Office & Locations
Head Office - Country
Shanghai Green Valley Pharmaceutical Co., Ltd. - Products and Services
Products
Services
Shanghai Green Valley Pharmaceutical Co., Ltd. - Corporate Strategy
Shanghai Green Valley Pharmaceutical Co., Ltd. - Business Description
Prescription Drugs
Generics
Consumer Health
Biosimilars and Specialty Pharmaceuticals
Shanghai Green Valley Pharmaceutical Co., Ltd. - ESG Spotlight
Environment
Social
Corporate Governance
Shanghai Green Valley Pharmaceutical Co., Ltd. - SWOT Spotlight
Overview
Strengths
Weaknesses
Opportunities
Threats
Competing Players
Snapshot of Competing Players
Biogen Inc
Key Company Facts
Company Description
Key Financials:
Eli Lilly and Company
Key Company Facts
Company Description
Key Financials:
Roche Holding AG
Key Company Facts
Company Description
Key Financials:
Takeda Pharmaceutical Company Limited
Key Company Facts
Company Description
Key Financials:
Merck & Co., Inc.
Key Company Facts
Company Description
Key Financials:
Shanghai Green Valley Pharmaceutical Co., Ltd. - In the News
13-May-2022- Announcement on Early Termination of GV-971 Global Multi-Center Phase III Clinical Trial
23-Dec-2021- GV-971 Gets Included in China National Reimbursement Drug ListGV-971 Gets Included in China National Reimbursement Drug List
02-Aug-2021- GV-971 Global Phase III Clinical Trial Completes First Patient Dosed in Greater China
25-Oct-2018- Novel Drug Treatment Shows Improved Cognition in a Phase 3 Clinical Trial in Persons with Mild-to-Moderate Alzheimer's Disease in China
25-Oct-2018- GV-971: Spearheading Global Drug Development for Alzheimer's Disease with A New Perspective
Appendix
Definitions
SWOT Analysis
PESTLE Analysis
Value Chain Analysis
ESG Spotlight
Research Methodology
Disclaimer
Contact Us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us